June 21, 2016   Amedica Corp. recently announced that it has submitted its responses to the U.S. Food and Drug Administration (FDA) in relation to the CASCADE clinical trial. The CASCADE study compared the 24-month outcomes from single-level cervical fusion between Amedica’s poroussilicon nitride vs. bone autograft. Data showed that porous silicon nitride achieved clinical […]